INSTATAB - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
85277030
Word Mark
INSTATAB
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2013-06-03
Filing Date
2011-03-25
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2012-09-04
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
EULIN, INGRID C
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2011-03-29
Primary Code
005
Correspondences
Name
Christopher L. Graff
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2011-03-29 | NEW APPLICATION ENTERED IN TRAM |
| 2011-03-29 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2011-06-09 | ASSIGNED TO EXAMINER |
| 2011-06-14 | NON-FINAL ACTION WRITTEN |
| 2011-06-14 | NON-FINAL ACTION E-MAILED |
| 2011-06-14 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2011-12-14 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2011-12-16 | ASSIGNED TO LIE |
| 2011-12-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2011-12-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2012-01-01 | FINAL REFUSAL WRITTEN |
| 2012-01-01 | FINAL REFUSAL E-MAILED |
| 2012-01-01 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2012-07-30 | EXAMINERS AMENDMENT -WRITTEN |
| 2012-07-30 | EXAMINERS AMENDMENT E-MAILED |
| 2012-07-30 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2012-07-31 | EXAMINER'S AMENDMENT ENTERED |
| 2012-07-31 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2012-07-31 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2012-08-15 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2012-09-04 | PUBLISHED FOR OPPOSITION |
| 2012-09-04 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2012-10-30 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2013-06-03 | ABANDONMENT - NO USE STATEMENT FILED |
| 2013-06-03 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 2014-01-22 | TEAS REVOKE/APPOINT ATTORNEY RECEIVED |
| 2014-01-22 | ATTORNEY REVOKED AND/OR APPOINTED |
| 2015-01-21 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
